Harnessing Liposome Interactions With the Immune System for the Next Breakthrough in Cancer Drug Delivery

• Հիմնական հեղինակներ: Ninh M. La-Beck (Հեղինակ), Xinli Liu (Հեղինակ), Laurence M. Wood (Հեղինակ)
• Ձևաչափ: Գիրք
• Հրապարակվել է: Frontiers Media S.A., 2019-03-01T00:00:00Z.
• Խորագրեր: article
• Առցանց հասանելիություն: Connect to this object online.

Liposomal nanoparticles are a heterogeneous group of engineered drug carriers that have tremendous therapeutic potential in the treatment of cancer. They increase tumor drug delivery, significantly attenuate drug toxicity, and protect the drug from degradation. However, two decades after approval of...